New York, January 17, 2013 -- Moody's Investors Service assigned a B1 rating to Healogics, Inc.'s ("Healogics") proposed $320 million senior secured first lien credit facilities, consisting of a $30 million revolver expiring 2018 and a $290 million first lien term loan due 2019. In addition, Moody's assigned a Caa1 rating to the proposed $110 million second lien term loan due 2020. Healogics' B2 Corporate Family Rating and B2-PD Probability of Default Ratings are affirmed. The outlook is stable.

Vollständigen Artikel bei Moodys lesen